Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data 
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface 
Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data 
Asian Currencies Slip as Dollar Strengthens; Indian Rupee Rebounds on Intervention Hopes 
Oil Prices Slip in Asia as 2026 Supply Glut Fears and Russia-Ukraine Talks Weigh on Markets 
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey 
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge 
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist 
Gold and Silver Surge as Safe Haven Demand Rises on U.S. Economic Uncertainty 
Oil Prices Rebound as Trump Orders Blockade of Sanctioned Venezuelan Tankers 
Japan PMI Data Signals Manufacturing Stabilization as Services Continue to Drive Growth 
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices 
China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand 
Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks 
Asian Stocks Slide as Central Bank Decisions and Key Data Keep Investors Cautious 
Ireland’s economic growth is expected to slow in 2024 as global risks mount, posing a significant challenge to its multinational-driven economy, the country's central bank warned. The bank revised its forecast for modified domestic demand (MDD) to 2.7% from 3.1%, citing uncertainty affecting consumption, exports, and investment.
A key concern is Ireland’s heavy reliance on U.S. multinational corporations, which contribute significantly to employment, tax revenue, and exports. U.S. President Donald Trump’s recent criticism of Ireland’s trade surplus and low corporate tax rate has intensified fears of economic disruption. His proposed 25% tariff on pharmaceutical imports and potential tax policy shifts could heavily impact Ireland’s economy, especially if companies are incentivized to relocate production and profits back to the U.S.
The foreign multinational sector, predominantly U.S.-owned, employs 11% of Ireland’s workforce and accounts for a major share of corporate tax revenue, which makes up 26% of total tax collected. The central bank warned that policy changes in Washington could cause a fiscal shock by significantly reducing corporate tax inflows.
Despite the risks, Ireland’s pharmaceutical exports to the U.S. have surged, growing by 68% year-on-year in January, driven partly by increased demand for weight-loss drugs. While some of this may be linked to stockpiling ahead of potential tariffs, absent any trade barriers, it could provide an unexpected boost to exports.
The central bank emphasized Ireland’s vulnerability to decisions made by a few multinational firms but noted possible upsides if export trends continue. As uncertainty looms, policymakers must navigate these risks to safeguard economic stability.
